With 0.57 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.18 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $26.92 whereas the lowest price it dropped to was $26.27. The 52-week range on WAY shows that it touched its highest point at $27.07 and its lowest point at $20.26 during that stretch. It currently has a 1-year price target of $29.44.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of WAY was down-trending over the past week, with a drop of -0.75%, but this was up by 12.74% over a month.
Float and Shares Shorts:
At present, 166.66 million WAY shares are outstanding with a float of 72.48 million shares on hand for trading. On 2024-07-31, short shares totaled 1.19 million, which was 72.000003 higher than short shares on 1719532800. In addition to Mr. Matthew J. Hawkins as the firm’s CEO & Director, Mr. Eric L. Sinclair III serves as its Chief Business Officer.
Institutional Ownership:
Through their ownership of 1.0348201 of WAY’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, WAY reported revenue of $234543000.0 and operating income of $8245000.0. The EBITDA in the recently reported quarter was $52545000.0 and diluted EPS was -$0.21.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for WAY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.
Dividends & Yield:
In terms of dividends, WAY has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and WAY currently yields $0.00. In the past year, WAY’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, WAY has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.
